Literature DB >> 12110406

Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease.

L M Ward1, F Rauch, R Travers, G Chabot, E M Azouz, L Lalic, P J Roughley, F H Glorieux.   

Abstract

Osteogenesis imperfecta (OI) is a heritable disease of bone with low bone mass and bone fragility. The disease is generally classified into four types based on clinical features and disease severity, although recently fifth and sixth forms have also been reported. Most forms of OI are autosomal dominant. Rarely, autosomal recessive disease has been described. We report the clinical, radiological, and histological features of four children (age 3.9-8.6 years at last follow-up; all girls) and four adults (age 28-33 years; two women) with a novel form of autosomal recessive OI living in an isolated First Nations community in northern Quebec. In keeping with the established numeric classification for OI forms, we have called this form of the disease OI type VII. The phenotype is moderate to severe, characterized by fractures at birth, bluish sclerae, early deformity of the lower extremities, coxa vara, and osteopenia. Rhizomelia is a prominent clinical feature. Histomorphometric analyses of iliac crest bone samples revealed findings similar to OI type I, with decreased cortical width and trabecular number, increased bone turnover, and preservation of the birefringent pattern of lamellar bone. The disease has subsequently been localized to chromosome 3p22-24.1, which is outside the loci for type I collagen genes. The underlying genetic basis for the disease remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12110406     DOI: 10.1016/s8756-3282(02)00790-1

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  61 in total

1.  A boy with blue sclera and recurrent fractures.

Authors:  N Md Shukri; I Mohamad; R Salim
Journal:  Malays Fam Physician       Date:  2015-04-30

2.  Case report: osteogenesis imperfecta Elusive cause of fractures.

Authors:  Elizabeth L Strevel; Alexandra Papaioannou; Jonathan D Adachi; Marty McNamara
Journal:  Can Fam Physician       Date:  2005-12       Impact factor: 3.275

Review 3.  Unexplained fractures in infancy: looking for fragile bones.

Authors:  Nick Bishop; Alan Sprigg; Ann Dalton
Journal:  Arch Dis Child       Date:  2007-03       Impact factor: 3.791

Review 4.  Bisphosphonates: effects on osteoblast.

Authors:  Nicola Maruotti; Addolorata Corrado; Anna Neve; Francesco Paolo Cantatore
Journal:  Eur J Clin Pharmacol       Date:  2012-02-09       Impact factor: 2.953

5.  [Bisphosphonate therapy for children and adolescents with primary and secondary osteoporotic diseases].

Authors:  O Semler; C Land; E Schönau
Journal:  Orthopade       Date:  2007-02       Impact factor: 1.087

6.  Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta.

Authors:  Wayne A Cabral; Weizhong Chang; Aileen M Barnes; MaryAnn Weis; Melissa A Scott; Sergey Leikin; Elena Makareeva; Natalia V Kuznetsova; Kenneth N Rosenbaum; Cynthia J Tifft; Dorothy I Bulas; Chahira Kozma; Peter A Smith; David R Eyre; Joan C Marini
Journal:  Nat Genet       Date:  2007-02-04       Impact factor: 38.330

Review 7.  Osteogenesis imperfecta and therapeutics.

Authors:  Roy Morello
Journal:  Matrix Biol       Date:  2018-03-11       Impact factor: 11.583

8.  Two novel COL1A1 mutations in patients with osteogenesis imperfecta (OI) affect the stability of the collagen type I triple-helix.

Authors:  Joanna Witecka; Aleksandra M Auguściak-Duma; Anna Kruczek; Anna Szydło; Marta Lesiak; Maria Krzak; Jacek J Pietrzyk; Minna Männikkö; Aleksander L Sieroń
Journal:  J Appl Genet       Date:  2008       Impact factor: 3.240

9.  Clinical and radiological manifestations of osteogenesis imperfecta type V.

Authors:  Dong Yeon Lee; Tae-Joon Cho; In Ho Choi; Chin Youb Chung; Won Joon Yoo; Ji Hyung Kim; Yong Koo Park
Journal:  J Korean Med Sci       Date:  2006-08       Impact factor: 2.153

10.  Osteopotentia regulates osteoblast maturation, bone formation, and skeletal integrity in mice.

Authors:  Michael L Sohaskey; Yebin Jiang; Jenny J Zhao; Andreas Mohr; Frank Roemer; Richard M Harland
Journal:  J Cell Biol       Date:  2010-05-03       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.